J. Lopes-Lima

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

António Gil‐Nagel, J. Lopes-Lima, Luís Almeida et al. · Acta Neurologica Scandinavica · 2009 · 162 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Integrated analysis of pooled data from double‐blind phase III clinical studies

António Gil‐Nagel, Christian E. Elger, Elinor Ben‐Menachem et al. · Epilepsia · 2012 · 86 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study

Fernando Dias Correia, Joel Freitas, Rui Magalhães et al. · Epilepsy Research · 2014 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +4